The European Medicines Agency has published a report focused on the mid-term achievements of its Regulatory Science Strategy to 2025. The strategy provides a plan for advancing regulatory science over a five-year period to be ready to support the development and assessment of ever more complex medicines that increasingly deliver healthcare solutions by converging different innovative technologies.

The report provides an overview of the main deliverables achieved between March 2020 and December 2022 across the human and veterinary areas.

In the human domain, progress was made in several areas, such as:

Work will continue in the period 2023-2025 to deliver the strategic goals to their fullest potential.

Read the report here!

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!

Pin It on Pinterest

Share This